Annual Information Update

Dechra Pharmaceuticals PLC
30 September 2005







Issued by Citigate Dewe Rogerson Limited, Birmingham
Date: Friday 30 September 2005


                                                               Immediate Release
                           Dechra Pharmaceuticals PLC
                         (the 'Company' or the 'Group')
                           Annual Information Update

The Report & Accounts for the year ended 30 June 2005 has been posted to
shareholders.

A copy of the Report and Accounts document has also been submitted to the UK
Listing Authority. Further copies are available on request from the Company
Secretary, Dechra Pharmaceuticals PLC, Dechra House, Jamage Industrial Estate,
Talke Pits, Stoke-on-Trent, ST7 1XW or from the Group web-site (www.dechra.com).

Under the new rules introduced on 1 July 2005 relating to Prospectus Directives
by the UKLA companies are required to list all regulatory news announcements
issued by the Company in the twelve month period preceding the date that the
published Accounts are issued to shareholders.

Dechra Pharmaceuticals PLC wish to advise that the following Regulatory News
Announcements have been issued by the Company over the period from 1 October
2004 to 30 September 2005:

30 September 2005   Annual Information Update
26 September 2005   Holding(s) in Company
23 September 2005   Report & Accounts for the year-ended 30 June 2005
                    published
19 September 2005   Holding(s) in Company
16 September 2005   Holding(s) in Company
13 September 2005   Holding(s) in Company
8 September 2005    Holding(s) in Company
6 September 2005    Preliminary Results for the year-ended 30 June 2005
24 August 2005      Holding(s) in Company
22 August 2005      Notice of Results (Final)
9 August 2005       Holding(s) in Company
9 August 2005       Director/PDMR Shareholding
19 July 2005        Holding(s) in Company
8 July 2005         Holding(s) in Company
5 July 2005         Pre-Closed Period Update
17 June 2005        Director Shareholding
1 June 2005         Holding(s) in Company
18 April 2005       Holding(s) in Company
12 April 2005       Additional Listing
5 April 2005        Licenses acquisition (Vetivex)
1 March 2005        Interim Results for the six months ended 31 December 2003
21 February 2005    Holding(s) in Company
17 February 2005    Worldwide Marketing Agreement (with Belcher Pharmaceuticals)
9 February 2005     Pharmaceutical Product Update
7 February 2005     Holding(s) in Company
1 February 2005     Statement re: Joint Venture (Vetcom Open/CamDal)
28 January 2005     Notice of Results (Interim)
17 January 2005     Holding(s) in Company
12 January 2005     Trading Update
24 December 2004    Additional Listing
14 December 2004    Additional Listing
19 November 2004    Additional Listing
9 November 2004     Additional Listing
21 October 2004     AGM Statement
12 October 2004     Additional Listing

Further details on the information contained within the above RNS announcements
can be viewed on the London Stock Exchange website: www.londonstockexchange.com
under code: DPH.

Enquiries:
Steve Whitehouse, Company Secretary    Dechra Pharmaceuticals PLC  Tel: [phone]






                      This information is provided by RNS
            The company news service from the London Stock Exchange